{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:03:43Z","timestamp":1789887823404,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Proteome Sci"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The success of new sequencing technologies and informatic methods for identifying genes has made establishing gene product function a critical rate limiting step in progressing the molecular sciences. We present a method to functionally mine genomes for useful activities <jats:italic>in vivo<\/jats:italic>, using an unusual property of a member of the poxvirus family to demonstrate this screening approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The genome of <jats:italic>Parapoxvirus ovis<\/jats:italic> (<jats:italic>Orf virus<\/jats:italic>) was sequenced, annotated, and then used to PCR-amplify its open-reading-frames. Employing a cloning-independent protocol, a viral expression-library was rapidly built and arrayed into sub-library pools. These were directly delivered into mice as expressible cassettes and assayed for an immune-modulating activity associated with parapoxvirus infection. The product of the B2L gene, a homolog of vaccinia F13L, was identified as the factor eliciting immune cell accumulation at sites of skin inoculation. Administration of purified B2 protein also elicited immune cell accumulation activity, and additionally was found to serve as an adjuvant for antigen-specific responses. Co-delivery of the B2L gene with an influenza gene-vaccine significantly improved protection in mice. Furthermore, delivery of the B2L expression construct, without antigen, non-specifically reduced tumor growth in murine models of cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A streamlined, functional approach to genome-wide screening of a biological activity <jats:italic>in vivo<\/jats:italic> is presented. Its application to screening in mice for an immune activity elicited by the pathogen genome of <jats:italic>Parapoxvirus ovis<\/jats:italic> yielded a novel immunomodulator. In this inverted discovery method, it was possible to identify the adjuvant responsible for a function of interest prior to a mechanistic study of the adjuvant. The non-specific immune activity of this modulator, B2, is similar to that associated with administration of inactivated particles to a host or to a live viral infection. Administration of B2 may provide the opportunity to significantly impact host immunity while being itself only weakly recognized. The functional genomics method used to pinpoint B2 within an ORFeome may be more broadly applicable to screening for other biological activities in an animal.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-5956-10-4","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T19:31:46Z","timestamp":1326483106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Novel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome"],"prefix":"10.1186","volume":"10","author":[{"given":"Michael J","family":"McGuire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn F","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,13]]},"reference":[{"key":"316_CR1","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","volume":"19","author":"R Rappuoli","year":"2001","unstructured":"Rappuoli R: Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001, 19: 2688\u20132691. 10.1016\/S0264-410X(00)00554-5","journal-title":"Vaccine"},{"key":"316_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000088839","volume":"9","author":"J Cui","year":"2005","unstructured":"Cui J, Han LY, Cai CZ, Zheng CJ, Ji ZL, Chen YZ: Prediction of functional class of novel bacterial proteins without the use of sequence similarity by a statistical learning method. J Mol Microbiol Biotechnol 2005, 9: 86\u2013100. 10.1159\/000088839","journal-title":"J Mol Microbiol Biotechnol"},{"key":"316_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0923-2508(00)00115-7","volume":"151","author":"GM Weinstock","year":"2000","unstructured":"Weinstock GM, Smajs D, Hardham J, Norris SJ: From microbial genome sequence to applications. Res Microbiol 2000, 151: 151\u2013158. 10.1016\/S0923-2508(00)00115-7","journal-title":"Res Microbiol"},{"key":"316_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1073\/pnas.0408782102","volume":"102","author":"DH Davies","year":"2005","unstructured":"Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y, Romero KM, Nguyen TT, Kalantari-Dehaghi M, Crotty S, et al.: Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 2005, 102: 547\u2013552. 10.1073\/pnas.0408782102","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1471-2164-12-213","volume":"12","author":"T Ketela","year":"2011","unstructured":"Ketela T, Heisler L, Brown K, Ammar R, Kasimer D, Surendra A, Ericson E, Blakely K, Karamboulas D, Smith A, et al.: A comprehensive platform for highly multiplexed mammalian functional genetic screens. BMC Genomics 2011, 12: 213. 10.1186\/1471-2164-12-213","journal-title":"BMC Genomics"},{"key":"316_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/377632a0","volume":"377","author":"MA Barry","year":"1995","unstructured":"Barry MA, Lai WC, Johnston SA: Protection against mycoplasma infection using expression-library immunization. Nature 1995, 377: 632\u2013635. 10.1038\/377632a0","journal-title":"Nature"},{"key":"316_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.virol.2009.09.008","volume":"395","author":"A Borovkov","year":"2009","unstructured":"Borovkov A, Magee DM, Loskutov A, Cano JA, Selinsky C, Zsemlye J, Lyons CR, Sykes K: New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens. Virology 2009, 395: 97\u2013113. 10.1016\/j.virol.2009.09.008","journal-title":"Virology"},{"key":"316_CR8","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.vaccine.2005.12.035","volume":"24","author":"D Li","year":"2006","unstructured":"Li D, Borovkov A, Vaglenov A, Wang C, Kim T, Gao D, Sykes KF, Kaltenboeck B: Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates. Vaccine 2006, 24: 2917\u20132927. 10.1016\/j.vaccine.2005.12.035","journal-title":"Vaccine"},{"key":"316_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmicb.2011.00227","volume":"2","author":"GC Whitlock","year":"2011","unstructured":"Whitlock GC, Robida MD, Judy BM, Qazi O, Brown KA, Deeraksa A, Taylor K, Massey S, Loskutov A, Borovkov AY, et al.: Protective antigens against glanders identified by expression library immunization. Front Microbiol 2011, 2: 227.","journal-title":"Front Microbiol"},{"key":"316_CR10","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1128\/JVI.77.11.6093-6100.2003","volume":"77","author":"JB Johnston","year":"2003","unstructured":"Johnston JB, McFadden G: Poxvirus Immunomodulatory Strategies: Current Perspectives. J Virol 2003, 77: 6093\u20136100. 10.1128\/JVI.77.11.6093-6100.2003","journal-title":"J Virol"},{"key":"316_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-0560.1975.tb00179.x","volume":"2","author":"JV Johannessen","year":"1975","unstructured":"Johannessen JV, Krogh HK, Solberg I, Dalen A, van Wijngaarden H, Johansen B: Human orf. J Cutan Pathol 1975, 2: 265\u2013283. 10.1111\/j.1600-0560.1975.tb00179.x","journal-title":"J Cutan Pathol"},{"key":"316_CR12","first-page":"311","volume":"29","author":"DM Haig","year":"1998","unstructured":"Haig DM, Mercer AA: Ovine diseases. Orf. Vet Res 1998, 29: 311\u2013326.","journal-title":"Vet Res"},{"key":"316_CR13","first-page":"127","volume-title":"Poxviruses. Birkhaeuser Advances in Infectious Diseases","author":"SB Fleming","year":"2007","unstructured":"Fleming SB, Mercer AA, Schmidt A, Weber O: Genus Parapoxvirus. In Poxviruses. Birkhaeuser Advances in Infectious Diseases. Edited by: Schmidt A, Wolff M, Kaufmann S. Birkhaeuser Verlag, Basel; 2007:127\u2013165."},{"key":"316_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0021-9975(88)90052-7","volume":"99","author":"DJ McKeever","year":"1988","unstructured":"McKeever DJ, Jenkinson DM, Hutchison G, Reid HW: Studies of the pathogenesis of orf virus infection in sheep. J Comp Pathol 1988, 99: 317\u2013328. 10.1016\/0021-9975(88)90052-7","journal-title":"J Comp Pathol"},{"key":"316_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vetmic.2009.07.027","volume":"140","author":"N Sch\u00fctze","year":"2010","unstructured":"Sch\u00fctze N, Raue R, B\u00fcttner M, K\u00f6hler G, McInnes CJ, Alber G: Specific antibodies induced by inactivated parapoxvirus ovis potently enhance oxidative burst in canine blood polymorphonuclear leukocytes and monocytes. Veterinary Microbiology 2010, 140: 81\u201391. 10.1016\/j.vetmic.2009.07.027","journal-title":"Veterinary Microbiology"},{"key":"316_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1439-0450.1997.tb01004.x","volume":"44","author":"KL Ziebell","year":"1997","unstructured":"Ziebell KL, Steinmann H, Kretzdorn D, Schlapp T, Failing K, Schmeer N: The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4\u201310 month old horses. Zentralbl Veterinarmed B 1997, 44: 529\u2013536. 10.1111\/j.1439-0450.1997.tb01004.x","journal-title":"Zentralbl Veterinarmed B"},{"key":"316_CR17","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1099\/vir.0.19138-0","volume":"84","author":"O Weber","year":"2003","unstructured":"Weber O, Siegling A, Friebe A, Limmer A, Schlapp T, Knolle P, Mercer A, Schaller H, Volk H-D: Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J Gen Virol 2003, 84: 1843\u20131852. 10.1099\/vir.0.19138-0","journal-title":"J Gen Virol"},{"key":"316_CR18","doi-asserted-by":"publisher","first-page":"9400","DOI":"10.1128\/JVI.78.17.9400-9411.2004","volume":"78","author":"A Friebe","year":"2004","unstructured":"Friebe A, Siegling A, Friederichs S, Volk H-D, Weber O: Immunomodulatory Effects of Inactivated Parapoxvirus Ovis (Orf Virus) on Human Peripheral Immune Cells: Induction of Cytokine Secretion in Monocytes and Th1-Like Cells. J Virol 2004, 78: 9400\u20139411. 10.1128\/JVI.78.17.9400-9411.2004","journal-title":"J Virol"},{"key":"316_CR19","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.1128\/JVI.74.17.7943-7951.2000","volume":"74","author":"V Fachinger","year":"2000","unstructured":"Fachinger V, Schlapp T, Strube W, Schmeer N, Saalmuller A: Poxvirus-induced immunostimulating effects on porcine leukocytes. J Virol 2000, 74: 7943\u20137951. 10.1128\/JVI.74.17.7943-7951.2000","journal-title":"J Virol"},{"key":"316_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0147-9571(99)00069-7","volume":"23","author":"G Castrucci","year":"2000","unstructured":"Castrucci G, Osburn BI, Frigeri F, Ferrari M, Salvatori D, Lo Dico M, Barreca F: The use of immunomodulators in the control of infectious bovine rhinotracheitis. Comparative Immunology, Microbiology and Infectious Diseases 2000, 23: 163\u2013173. 10.1016\/S0147-9571(99)00069-7","journal-title":"Comparative Immunology, Microbiology and Infectious Diseases"},{"key":"316_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K: Immunobiology of Dendritic Cells. Annual Review of Immunology 2000, 18: 767\u2013811. 10.1146\/annurev.immunol.18.1.767","journal-title":"Annual Review of Immunology"},{"key":"316_CR22","doi-asserted-by":"crossref","unstructured":"Igyarto BZ, Kaplan DH: The evolving function of Langerhans cells in adaptive skin immunity. Immunol Cell Biol 88: 361\u2013365.","DOI":"10.1038\/icb.2010.24"},{"key":"316_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0147-9571(96)00045-8","volume":"20","author":"DM Haig","year":"1997","unstructured":"Haig DM, McInnes C, Deane D, Reid H, Mercer A: The immune and inflammatory response to orf virus. Comp Immunol Microbiol Infect Dis 1997, 20: 197\u2013204. 10.1016\/S0147-9571(96)00045-8","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"316_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/7908","volume":"17","author":"KF Sykes","year":"1999","unstructured":"Sykes KF, Johnston SA: Linear expression elements: a rapid, in vivo, method to screen for gene functions. Nat Biotechnol 1999, 17: 355\u2013359. 10.1038\/7908","journal-title":"Nat Biotechnol"},{"key":"316_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/icb.2010.39","volume":"88","author":"N Romani","year":"2010","unstructured":"Romani N, Thurnher M, Idoyaga J, Steinman RM, Flacher V: Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunol Cell Biol 2010, 88: 424\u2013430. 10.1038\/icb.2010.39","journal-title":"Immunol Cell Biol"},{"key":"316_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1006\/viro.1994.1420","volume":"202","author":"JT Sullivan","year":"1994","unstructured":"Sullivan JT, Mercer AA, Fleming SB, Robinson AJ: Identification and characterization of an orf virus homologue of the vaccinia virus gene encoding the major envelope antigen p37K. Virology 1994, 202: 968\u2013973. 10.1006\/viro.1994.1420","journal-title":"Virology"},{"key":"316_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.0022-202X.2004.23427.x","volume":"123","author":"M Dupasquier","year":"2004","unstructured":"Dupasquier M, Stoitzner P, van Oudenaren A, Romani N, Leenen PJ: Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol 2004, 123: 876\u2013879. 10.1111\/j.0022-202X.2004.23427.x","journal-title":"J Invest Dermatol"},{"key":"316_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/sj.icb.7100047","volume":"85","author":"CE Angel","year":"2007","unstructured":"Angel CE, George E, Ostrovsky LL, Dunbar PR: Comprehensive analysis of MHC-II expression in healthy human skin. Immunol Cell Biol 2007, 85: 363\u2013369. 10.1038\/sj.icb.7100047","journal-title":"Immunol Cell Biol"},{"key":"316_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0042-6822(92)90313-E","volume":"187","author":"LG Payne","year":"1992","unstructured":"Payne LG: Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation. Virology 1992, 187: 251\u2013260. 10.1016\/0042-6822(92)90313-E","journal-title":"Virology"},{"key":"316_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","volume":"9","author":"RM Steinman","year":"1991","unstructured":"Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9: 271\u2013296. 10.1146\/annurev.iy.09.040191.001415","journal-title":"Annu Rev Immunol"},{"key":"316_CR31","first-page":"61","volume":"44","author":"J Narbutt","year":"2006","unstructured":"Narbutt J, Lesiak A, Sysa-Jedrzejowska A, Smolewski P, Robak T, Zalewska A: The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects. Folia Histochem Cytobiol 2006, 44: 61\u201363.","journal-title":"Folia Histochem Cytobiol"},{"key":"316_CR32","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.4049\/jimmunol.170.11.5483","volume":"170","author":"L Timares","year":"2003","unstructured":"Timares L, Safer KM, Qu B, Takashima A, Johnston SA: Drug-inducible, dendritic cell-based genetic immunization. J Immunol 2003, 170: 5483\u20135490.","journal-title":"J Immunol"},{"key":"316_CR33","doi-asserted-by":"publisher","first-page":"13147","DOI":"10.1073\/pnas.95.22.13147","volume":"95","author":"L Timares","year":"1998","unstructured":"Timares L, Takashima A, Johnston SA: Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc Natl Acad Sci USA 1998, 95: 13147\u201313152. 10.1073\/pnas.95.22.13147","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR34","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.4049\/jimmunol.164.5.2487","volume":"164","author":"SM Barratt-Boyes","year":"2000","unstructured":"Barratt-Boyes SM, Zimmer MI, Harshyne LA, Meyer EM, Watkins SC, Capuano S, Murphey-Corb M, Falo LD Jr, Donnenberg AD: Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J Immunol 2000, 164: 2487\u20132495.","journal-title":"J Immunol"},{"key":"316_CR35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/1523-1747.ep12292095","volume":"108","author":"CM Celluzzi","year":"1997","unstructured":"Celluzzi CM, Falo LD Jr: Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity. J Invest Dermatol 1997, 108: 716\u2013720. 10.1111\/1523-1747.ep12292095","journal-title":"J Invest Dermatol"},{"key":"316_CR36","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.1128\/JVI.00034-07","volume":"81","author":"KM Honeychurch","year":"2007","unstructured":"Honeychurch KM, Yang G, Jordan R, Hruby DE: The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus. J Virol 2007, 81: 7310\u20137315. 10.1128\/JVI.00034-07","journal-title":"J Virol"},{"key":"316_CR37","doi-asserted-by":"publisher","first-page":"7528","DOI":"10.1128\/JVI.75.16.7528-7542.2001","volume":"75","author":"M Husain","year":"2001","unstructured":"Husain M, Moss B: Vaccinia Virus F13L Protein with a Conserved Phospholipase Catalytic Motif Induces Colocalization of the B5R Envelope Glycoprotein in Post-Golgi Vesicles. J Virol 2001, 75: 7528\u20137542. 10.1128\/JVI.75.16.7528-7542.2001","journal-title":"J Virol"},{"key":"316_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","volume":"306","author":"JW Hooper","year":"2003","unstructured":"Hooper JW, Custer DM, Thompson E: Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 2003, 306: 181\u2013195. 10.1016\/S0042-6822(02)00038-7","journal-title":"Virology"},{"key":"316_CR39","doi-asserted-by":"publisher","first-page":"8763","DOI":"10.1128\/JVI.00598-06","volume":"80","author":"B Perdiguero","year":"2006","unstructured":"Perdiguero B, Blasco R: Interaction between Vaccinia Virus Extracellular Virus Envelope A33 and B5 Glycoproteins. J Virol 2006, 80: 8763\u20138777. 10.1128\/JVI.00598-06","journal-title":"J Virol"},{"key":"316_CR40","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1093\/emboj\/16.15.4519","volume":"16","author":"TC Sung","year":"1997","unstructured":"Sung TC, Roper RL, Zhang Y, Rudge SA, Temel R, Hammond SM, Morris AJ, Moss B, Engebrecht J, Frohman MA: Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J 1997, 16: 4519\u20134530. 10.1093\/emboj\/16.15.4519","journal-title":"EMBO J"},{"key":"316_CR41","first-page":"3706","volume":"41","author":"JJ Vitale","year":"1981","unstructured":"Vitale JJ, Broitman SA: Lipids and immune function. Cancer Res 1981, 41: 3706\u20133710.","journal-title":"Cancer Res"},{"key":"316_CR42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1101\/gr.8.7.741","volume":"8","author":"S Rayner","year":"1998","unstructured":"Rayner S, Brignac S, Bumeister R, Belosludtsev Y, Ward T, Grant O, O'Brien K, Evans GA, Garner HR: MerMade: an oligodeoxyribonucleotide synthesizer for high throughput oligonucleotide production in dual 96-well plates. Genome Res 1998, 8: 741\u2013747.","journal-title":"Genome Res"},{"key":"316_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1101\/gr.1.2.120","volume":"1","author":"PE Nisson","year":"1991","unstructured":"Nisson PE, Rashtchian A, Watkins PC: Rapid and efficient cloning of Alu-PCR products using uracil DNA glycosylase. PCR Methods Appl 1991, 1: 120\u2013123.","journal-title":"PCR Methods Appl"},{"key":"316_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0076-6879(87)53044-0","volume":"153","author":"J Vieira","year":"1987","unstructured":"Vieira J, Messing J: Production of single-stranded plasmid DNA. Methods Enzymol 1987, 153: 3\u201311.","journal-title":"Methods Enzymol"},{"key":"316_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0264-410X(01)00352-8","volume":"20","author":"AM Talaat","year":"2001","unstructured":"Talaat AM, Lyons R, Johnston SA: A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses. Vaccine 2001, 20: 538\u2013544. 10.1016\/S0264-410X(01)00352-8","journal-title":"Vaccine"}],"container-title":["Proteome Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-5956-10-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:16:58Z","timestamp":1630520218000},"score":1,"resource":{"primary":{"URL":"https:\/\/proteomesci.biomedcentral.com\/articles\/10.1186\/1477-5956-10-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1186\/1477-5956-10-4","relation":{},"ISSN":["1477-5956"],"issn-type":[{"value":"1477-5956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,13]]},"assertion":[{"value":"30 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}